Toripalimab Plus Neoadjuvant Chemotherapy Combined With Chemoradiotherapy for Locally Advanced Unresectable Esophageal Squamous Cell Carcinoma

NCT04844385 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

124

Enrollment

OTHER

Sponsor class

Conditions

Esophageal Squamous Cell Carcinoma

Interventions

DRUG: Toripalimab
DRUG: Paclitaxel-albumin
DRUG: Nedaplatin
RADIATION: radiation therapy at a total dose 60 Gy
DRUG: Capecitabine
RADIATION: radiation therapy at a total dose 50 Gy

Sponsor

Sun Yat-sen University